China's HGR regime has been significantly bolstered in the last two years, delaying the research and development activities of biopharma MNCs in the country
Legal
- May 14, 2021
China's HGR regime still delays foreign-sponsored clinical research despite recent streamlining of review process
May 14, 2021European Commission releases draft regulation tightening requirements on foreign state-backed investors; Mainland-Hong Kong wealth link imminent following release of implementation rules; and Shanghai to trial first-ever options contract available to foreign investors
May 10, 2021Operators of critical information infrastructure bear heightened counter-espionage security obligations
May 07, 2021Live streaming marketing platforms are required to protect consumer rights and personal data privacy
May 07, 2021Clear users' consent is required for processing information by an App. Foreign banks are exempted from risk exposure requirements. Catering service providers are required to provide clear information to customers to prevent waste of food.
May 07, 2021Being the first U.S. domestic issuer to have a secondary listing in Hong Kong required navigating difficult SEC and SFC requirements
May 07, 2021Yum China has had an eventful year, navigating the impact of the pandemic on its many restaurants and staff in China, as well as a groundbreaking secondary listing in Hong Kong
May 07, 2021MIIT issues the first draft guidelines for intelligent connected vehicles
May 05, 2021China failing to protect U.S. companies' IP according to USTR report; French banking giant BNP Paribas applies for securities business; and PRC Futures Law submitted to NPCSC for first reading
May 03, 2021






